Evidence for enhanced central memory priming by live Mycobacterium bovis BCG vaccine in comparison with killed BCG formulations

Vaccine

Volumn 26, Issue 2, 2008, Pages 166-173

  Whelan, Adam O ^a   Wright, D Craig ^b   Chambers, Mark A ^a   Singh, Mahavir ^c   Hewinson, R Glyn ^a   Vordermeier, H Martin ^a  

^a VETERINARY LABORATORIES AGENCY   (United Kingdom)

^b Helmholz Centre for Biotechnology ^*  (United States)

^c Division of Microbiology   (Germany)

Author keywords

Adjuvant; BCG; Cattle; Mycobacterium bovis; Vaccine

Indexed keywords

85A ANTIGEN; BACTERIAL ANTIGEN; FORMALDEHYDE; IMMUNOLOGICAL ADJUVANT; LIPOSOME; MYCOBACTERIUM VACCINE; NAX 687; NOVASOME; UNCLASSIFIED DRUG;

AEROSOL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BCG VACCINATION; CALF (BOVINE); CATTLE DISEASE; CONTROLLED STUDY; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG FORMULATION; EFFECTOR CELL; GUINEA PIG; HUMORAL IMMUNITY; IMMUNOGENICITY; INFECTION PREVENTION; MEMORY T LYMPHOCYTE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BCG VACCINE; CATTLE; CATTLE DISEASES; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOGLOBULIN G; IMMUNOLOGIC MEMORY; INTERFERON TYPE II; MYCOBACTERIUM BOVIS; T-LYMPHOCYTES; TUBERCULOSIS; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 37249038473     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.11.005     Document Type: Article

References (49)

1. Gallagher J., and Clifton-Hadley R.S. Tuberculosis in badgers; a review of the disease and its significance for other animals. Res Vet Sci 69 3 (2000) 203-217
2. O'brien D.J., Schmitt S.M., Fitzgerald S.D., Berry D.E., and Hickling G.J. Managing the wildlife reservoir of Mycobacterium bovis: the Michigan, USA, experience. Vet Microbiol 112 2-4 (2006) 313-323
3. Michel A.L., Bengis R.G., Keet D.F., Hofmeyr M., Klerk L.M., Cross P.C., et al. Wildlife tuberculosis in South African conservation areas: implications and challenges. Vet Microbiol 112 2-4 (2006) 91-100
4. Ryan T.J., Livingstone P.G., Ramsey D.S., de Lisle G.W., Nugent G., Collins D.M., et al. Advances in understanding disease epidemiology and implications for control and eradication of tuberculosis in livestock: the experience from New Zealand. Vet Microbiol 112 2-4 (2006) 211-219
5. Nishi J., Kaname T., Yoshinaga M., Nagai T., Murakami N., Kataoka N., et al. A case of non-tuberculous mycobacterial lymphadenitis diagnosed with new skin tests and PCR. Acta Paediatr Jpn 36 4 (1994) 453-456
6. Thoen C., Lobue P., and de Kantor I. The importance of Mycobacterium bovis as a zoonosis. Vet Microbiol 112 2-4 (2006) 339-345
7. Cosivi O., Grange J.M., Daborn C.J., Raviglione M.C., Fujikura T., Cousins D., et al. Zoonotic tuberculosis due to Mycobacterium bovis in developing countries. Emerg Infect Dis 4 1 (1998) 59-70
8. Kazwala R.R., Daborn C.J., Sharp J.M., Kambarage D.M., Jiwa S.F.H., and Mbembati N.A. Isolation of Mycobacterium bovis from human cases of cervical adenitis in Tanzania: a cause for concern?. Int J Tuberc Lung Dis 5 (2001) 87-91
9. Rodrigues L.C., Diwan V.K., and Wheeler J.G. Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis. Int J Epidemiol 22 6 (1993) 1154-1158
10. Colditz G.A., Brewer T.F., Berkey C.S., Wilson M.E., Burdick E., Fineberg H.V., et al. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature. JAMA 271 9 (1994) 698-702
11. Brewer T.F. Preventing tuberculosis with bacillus Calmette-Guerin vaccine: a meta-analysis of the literature. Clin Infect Dis 31 3 (2000) 64-67
12. Fine P.E. Variation in protection by BCG: implications of and for heterologous immunity. Lancet 346 8986 (1995) 1339-1345
13. Skinner M.A., Wedlock D.N., and Buddle B.M. Vaccination of animals against Mycobacterium bovis. Rev Sci Tech 20 1 (2001) 112-132
14. Hewinson R.G., Vordermeier H.M., and Buddle B.M. Use of the bovine model of tuberculosis for the development of improved vaccines and diagnostics. Tuberculosis (Edinb) 83 1-3 (2003) 119-130
15. Vordermeier M., and Hewinson R.G. Development of cattle TB vaccines in the UK. Vet Immunol Immunopathol 112 1-2 (2006) 38-48
16. Baumann S., Nasser Eddine A., and Kaufmann S.H. Progress in tuberculosis vaccine development. Curr Opin Immunol 18 4 (2006) 438-448
17. Orme I.M. Induction of nonspecific acquired resistance and delayed-type hypersensitivity, but not specific acquired resistance in mice inoculated with killed mycobacterial vaccines. Infect Immun 56 12 (1988) 3310-3312
18. Griffin J.F., Mackintosh C.G., Slobbe L., Thomson A.J., and Buchan G.S. Vaccine protocols to optimise the protective efficacy of BCG. Tuber Lung Dis 79 3 (1999) 135-143
19. Buddle B.M., Keen D., Thomson A., Jowett G., McCarthy A.R., Heslop J., et al. Protection of cattle from bovine tuberculosis by vaccination with BCG by the respiratory or subcutaneous route, but not by vaccination with killed Mycobacterium vaccae. Res Vet Sci 59 1 (1995) 10-16
20. Chambers M.A., Wright D.C., Brisker J., Williams A., Hatch G., Gavier-Widen D., et al. A single dose of killed Mycobacterium bovis BCG in a novel class of adjuvant (Novasome) protects guinea pigs from lethal tuberculosis. Vaccine 22 8 (2004) 1063-1071
21. Haile M., Schroder U., Hamasur B., Pawlowski A., Jaxmar T., Kallenius G., et al. Immunisations with heat-killed Mycobacterium bovis bacille Calmette-Guerin (BCG) in Eurocine L3 adjuvant protects against tuberculosis. Vaccine 22 11-12 (2004) 1498-1508
22. Hesseling A.C., Marais B.J., Gie R.P., Schaaf H.S., Fine P.E., Godfrey-Faussett P., et al. The risk of disseminated Bacille Calmette-Guerin (BCG) disease in HIV-infected children. Vaccine 25 1 (2007) 14-18
23. Sallusto F., Lendig D., Forster R., Lipp M., and Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 401 6754 (1999) 708-712
24. Sallusto F., Geginat J., and Lanzavecchia A. Central memory and effector memory T cell subsets: function, generation and maintenance. Ann Rev Immunol 22 (2004) 745-763
25. Godkin A.J., Thomas H.C., and Openshaw P.J. Evolution of epitope-specific memory CD4(+) T cells after clearance of hepatitis C virus. J Immunol 169 4 (2002) 2210-2214
26. Gallagher J., and Horwill D.M. A selective oleic acid albumin agar medium for the cultivation of Mycobacterium bovis. J Hyg (Lond) 79 1 (1977) 155-160
27. Vordermeier H.M., Cockle P.C., Whelan A., Rhodes S., Palmer N., Bakker D., et al. Development of diagnostic reagents to differentiate between Mycobacterium bovis BCG vaccination and M. bovis infection in cattle. Clin Diagn Lab Immunol 6 5 (1999) 675-682
28. Vordermeier H.M., Chambers M.A., Cockle P.J., Whelan A.O., Simmons J., and Hewinson R.G. Correlation of ESAT-6-specific gamma interferon production with pathology in cattle following Mycobacterium bovis BCG vaccination against experimental bovine tuberculosis. Infect Immun 70 6 (2002) 3026-3032
29. Vordermeier H.M., Huygen K., Singh M., Hewinson R.G., and Xing Z. Immune responses induced in cattle by vaccination with a recombinant adenovirus expressing Mycobacterial antigen 85A and Mycobacterium bovis BCG. Infect Immun 74 2 (2006) 1416-1418
30. Vordermeier H.M., Rhodes S.G., Dean G., Goonetilleke N., Huygen K., Hill A.V., et al. Cellular immune responses induced in cattle by heterologous prime-boost vaccination using recombinant viruses and bacille Calmette-Guerin. Immunology 112 3 (2004) 461-470
31. North R.J., and Jung Y.J. Immunity to tuberculosis. Annu Rev Immunol 22 (2004) 599-623
32. Chambers M.A., Marshall B.G., Wangoo A., Bune A., Cook H.T., Shaw R.J., et al. Differential responses to challenge with live and dead Mycobacterium bovis Bacillus Calmette-Guerin. J Immunol 158 4 (1997) 1742-1748
33. Fortin A., and Therien H.M. Mechanism of liposome adjuvanticity: an in vivo approach. Immunobiology 188 3 (1993) 316-322
34. Gupta R.K., Varanelli C.L., Griffin P., Wallach D.F., and Siber G.R. Adjuvant properties of non-phospholipid liposomes (Novasomes) in experimental animals for human vaccine antigens. Vaccine 14 3 (1996) 219-225
35. Dietrich J., Billeskov R., Doherty T.M., and Andersen P. Synergistic effect of bacillus calmette guerin and a tuberculosis subunit vaccine in cationic liposomes: increased immunogenicity and protection. J Immunol 178 6 (2007) 3721-3730
36. Wedlock D.N., Skinner M.A., Parlane N.A., Vordermeier H.M., Hewinson R.G., de Lisle G.W., et al. Vaccination with DNA vaccines encoding MPB70 or MPB83 or a MPB70 DNA prime-protein boost does not protect cattle against bovine tuberculosis. Tuberculosis (Edinb) 83 6 (2003) 339-349
37. Power C.A., Wei G., and Bretscher P.A. Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route. Infect Immun 66 12 (1998) 5743-5750
38. Gruppo V., and Orme I.M. Dose of BCG does not influence the efficient generation of protective immunity in mice challenged with Mycobacterium tuberculosis. Tuberculosis (Edinb) 82 6 (2002) 267-273
39. Andersen P., Askgaard D., Ljungqvist L., Bentzon M.W., and Heron I. T-cell proliferative response to antigens secreted by Mycobacterium tuberculosis. Infect Immun 59 4 (1991) 1558-1563
40. Gulle H., Fray L.M., Gormley E.P., Murray A., and Moriarty K.M. Responses of bovine T cells to fractionated lysate and culture filtrate proteins of Mycobacterium bovis BCG. Vet Immunol Immunopathol 48 1-2 (1995) 183-190
41. Skjot R.L., Oettinger T., Rosenkrands I., Ravn P., Brock I., Jacobsen S., et al. Comparative evaluation of low-molecular-mass proteins from Mycobacterium tuberculosis identifies members of the ESAT-6 family as immunodominant T-cell antigens. Infect Immun 68 1 (2000) 214-220
42. Aagaard C., Govaerts M., Meng Okkels L., Andersen P., and Pollock J.M. Genomic approach to identification of Mycobacterium bovis diagnostic antigens in cattle. J Clin Microbiol 41 3 (2003) 719-728
43. McShane H., Pathan A.A., Sander C.R., Keating S.M., Gilbert S.C., Huygen K., et al. Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humans. Nat Med 10 11 (2004) 1240-1244
44. Ng K.H., Aldwell F.E., Wedlock D.N., Watson J.D., and Buddle B.M. Antigen-induced interferon-gamma and interleukin-2 responses of cattle inoculated with Mycobacterium bovis. Vet Immunol Immunopathol 57 1-2 (1997) 59-68
45. Rhodes S.G., Buddle B.M., Hewinson R.G., and Vordermeier H.M. Bovine tuberculosis: immune responses in the peripheral blood and at the site of active disease. Immunology 99 2 (2000) 195-202
46. Tollefsen S., Vordermeier M., Olsen I., Storset A.K., Reitan L.J., Clifford D., et al. DNA injection in combination with electroporation: a novel method for vaccination of farmed ruminants. Scand J Immunol 57 3 (2003) 229-238
47. Reece W.H., Pinder M., Gothard P.K., Milligan P., Bojang K., Doherty T., et al. A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease. Nat Med 10 4 (2004) 406-410
48. Keating S.M., Bejon P., Berthoud T., Vuola J.M., Todryk S., Webster D.P., et al. Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria. J Immunol 175 9 (2005) 5675-5680
49. Goletti D., Butera O., Bizzoni F., Casetti R., Girardi E., and Poccia F. Region of difference 1 antigen-specific CD4+ memory T cells correlate with a favorable outcome of tuberculosis. J Infect Dis 194 7 (2006) 984-992